Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear

DRUG2 trials

Sponsors

Allergan

Conditions

Dry Eye Syndrome

Unknown Phase

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

CompletedNCT00932477

AllerganDry Eye Syndrome

Start: 2009-08-31End: 2009-09-30Updated: 2015-08-26

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

CompletedNCT01010282

AllerganDry Eye Syndrome

Start: 2009-11-30End: 2010-04-30Updated: 2015-08-17

Related Papers

Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.

2015-02-0427 citations